Table of Content

1. Executive Summary
   1.1. Global Interventional Oncology Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Product Adoption Analysis
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. Global Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Global Interventional Oncology Market Outlook: Product
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
           4.3.3.1. Radiation Therapy Devices
           4.3.3.2. Ablation Devices
               4.3.3.2.1. Microwave ablation
               4.3.3.2.2. Radiofrequency ablation
               4.3.3.2.3. Cryoablation
               4.3.3.2.4. Others
           4.3.3.3. Embolization Devices
               4.3.3.3.1. Microcatheters
               4.3.3.3.2. Guidewires
   4.4. Market Attractiveness Analysis: Product
   4.5. Global Interventional Oncology Market Outlook: Cancer Type
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Cancer Type, 2018 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
           4.5.3.1. Lung Cancer
           4.5.3.2. Liver Cancer
           4.5.3.3. Kidney Cancer
           4.5.3.4. Others
   4.6. Market Attractiveness Analysis: Cancer Type
   4.7. Global Interventional Oncology Market Outlook: End User
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
       4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
           4.7.3.1. Hospitals
           4.7.3.2. Specialty Clinics
           4.7.3.3. Ambulatory Surgical Center
           4.7.3.4. Others
   4.8. Market Attractiveness Analysis: End User
5. Global Interventional Oncology Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Product
       6.2.3. By Cancer Type
       6.2.4. By Route of Administration
       6.2.5. By End User
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       6.4.1. Radiation Therapy Devices
       6.4.2. Ablation Devices
           6.4.2.1. Microwave ablation
           6.4.2.2. Radiofrequency ablation
           6.4.2.3. Cryoablation
           6.4.2.4. Others
       6.4.3. Embolization Devices
           6.4.3.1. Microcatheters
           6.4.3.2. Guidewires
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       6.5.1. Lung Cancer
       6.5.2. Liver Cancer
       6.5.3. Kidney Cancer
       6.5.4. Others
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       6.6.1. Hospitals
       6.6.2. Specialty Clinics
       6.6.3. Ambulatory Surgical Center
       6.6.4. Others
   6.7. Market Attractiveness Analysis
7. Europe Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Product
       7.2.3. By Cancer Type
       7.2.4. By Route of Administration
       7.2.5. By End User
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       7.4.1. Radiation Therapy Devices
       7.4.2. Ablation Devices
           7.4.2.1. Microwave ablation
           7.4.2.2. Radiofrequency ablation
           7.4.2.3. Cryoablation
           7.4.2.4. Others
       7.4.3. Embolization Devices
           7.4.3.1. Microcatheters
           7.4.3.2. Guidewires
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       7.5.1. Lung Cancer
       7.5.2. Liver Cancer
       7.5.3. Kidney Cancer
       7.5.4. Others
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       7.6.1. Hospitals
       7.6.2. Specialty Clinics
       7.6.3. Ambulatory Surgical Center
       7.6.4. Others
   7.7. Market Attractiveness Analysis
8. East Asia Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Product
       8.2.3. By Cancer Type
       8.2.4. By Route of Administration
       8.2.5. By End User
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       8.4.1. Radiation Therapy Devices
       8.4.2. Ablation Devices
           8.4.2.1. Microwave ablation
           8.4.2.2. Radiofrequency ablation
           8.4.2.3. Cryoablation
           8.4.2.4. Others
       8.4.3. Embolization Devices
           8.4.3.1. Microcatheters
           8.4.3.2. Guidewires
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       8.5.1. Lung Cancer
       8.5.2. Liver Cancer
       8.5.3. Kidney Cancer
       8.5.4. Others
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       8.6.1. Hospitals
       8.6.2. Specialty Clinics
       8.6.3. Ambulatory Surgical Center
       8.6.4. Others
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Product
       9.2.3. By Cancer Type
       9.2.4. By Route of Administration
       9.2.5. By End User
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       9.4.1. Radiation Therapy Devices
       9.4.2. Ablation Devices
           9.4.2.1. Microwave ablation
           9.4.2.2. Radiofrequency ablation
           9.4.2.3. Cryoablation
           9.4.2.4. Others
       9.4.3. Embolization Devices
           9.4.3.1. Microcatheters
           9.4.3.2. Guidewires
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       9.5.1. Lung Cancer
       9.5.2. Liver Cancer
       9.5.3. Kidney Cancer
       9.5.4. Others
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       9.6.1. Hospitals
       9.6.2. Specialty Clinics
       9.6.3. Ambulatory Surgical Center
       9.6.4. Others
   9.7. Market Attractiveness Analysis
10. Latin America Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Product
       10.2.3. By Cancer Type
       10.2.4. By Route of Administration
       10.2.5. By End User
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       10.4.1. Radiation Therapy Devices
       10.4.2. Ablation Devices
           10.4.2.1. Microwave ablation
           10.4.2.2. Radiofrequency ablation
           10.4.2.3. Cryoablation
           10.4.2.4. Others
       10.4.3. Embolization Devices
           10.4.3.1. Microcatheters
           10.4.3.2. Guidewires
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       10.5.1. Lung Cancer
       10.5.2. Liver Cancer
       10.5.3. Kidney Cancer
       10.5.4. Others
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       10.6.1. Hospitals
       10.6.2. Specialty Clinics
       10.6.3. Ambulatory Surgical Center
       10.6.4. Others
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Interventional Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Product
       11.2.3. By Cancer Type
       11.2.4. By Route of Administration
       11.2.5. By End User
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 - 2031
       11.4.1. Radiation Therapy Devices
       11.4.2. Ablation Devices
           11.4.2.1. Microwave ablation
           11.4.2.2. Radiofrequency ablation
           11.4.2.3. Cryoablation
           11.4.2.4. Others
       11.4.3. Embolization Devices
           11.4.3.1. Microcatheters
           11.4.3.2. Guidewires
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Cancer Type, 2023 - 2031
       11.5.1. Lung Cancer
       11.5.2. Liver Cancer
       11.5.3. Kidney Cancer
       11.5.4. Others
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       11.6.1. Hospitals
       11.6.2. Specialty Clinics
       11.6.3. Ambulatory Surgical Center
       11.6.4. Others
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Profound Medical
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Medtronic Plc.
       12.3.3. Hologic, Inc.
       12.3.4. Boston Scientific Corporation
       12.3.5. AngioDynamics
       12.3.6. Terumo Corporation
       12.3.7. Teleflex Incorporated
       12.3.8. Alpinion Medical Systems Co. Ltd.
       12.3.9. Siemens Healthineers
       12.3.10. Merit Medical
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations